Tammi S.

Cleveland, OH

Tammi’s Testimonial for COPD Treatment at the Lung Institute

Age: 41 | Location: Cleveland, OH | Condition: COPD

When daily chores, walking and having a conversation left her out of breath, Tammi S. knew it was time to try something different for her chronic obstructive pulmonary disease (COPD). She contacted the Lung Institute to learn more about stem cell treatment options. She spoke with Lung Institute staff several times before she decided to have treatment in August 2015.

Tammi and her family noticed improvements to her health quickly, and over time, Tammi’s daily activities increased. Now, Tammi can walk, have a conversation and polish her own nails without feeling short of breath. Interested in what her pulmonary function test (PFT) would report, Tammi went to her doctor. Skeptical he would see improvement, the doctor performed a PFT, finding that Tammi’s lung function went from 58% before treatment to 78% after treatment. Tammi looks forward to continued improvement and says she doesn’t have a cough, feels happy and loves life.

If you or a loved one has COPD, or another lung disease, and would like to see results like Tammi’s, contact us at (800) 729-3065 to learn more.

Nancy H.
Bellingham, WA
David V.
Englewood, FL
Herbert K.
Keller, TX
Don C.
Lakewood, OH
Jerry E.
Kernersville, NC
Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Rhonda S.
Macomb, MI
Tammi S.
Cleveland, OH
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Michael F.
Georgetown, TX
Susan B.
Edison, NJ
Lois S.
Sun City, AZ
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Jim D.
Boca Raton, FL
Marvin S.
Lakeland, FL
Vickie B.
San Antonio, TX
Audrey S.
Fairbanks, AK
Linus S.
Hays, KS

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.